Catheter and Urinary Tract Complication Documentation
- Urethral catheter management instructions are a required component of discharge documentation for urological procedures that result in the patient being discharged with an indwelling urethral catheter, including radical prostatectomy, transurethral resection of the prostate (TURP), and cystoscopy with bladder neck procedures. Discharge instructions must specify the catheter size and type, the drainage bag management instructions (emptying frequency, securing the catheter to prevent traction injury, cleaning the catheter-meatus junction), the catheter removal date and location, and the signs of catheter malfunction or displacement requiring provider contact: cessation of urine output, gross hematuria with clots causing catheter obstruction, urethral pain or bleeding around the catheter, and fever above 101 degrees Fahrenheit. Patients sent home with catheters who do not receive explicit written catheter management instructions are at elevated risk of unplanned emergency department visits for catheter-related complications.
- Urinary retention risk documentation is required for procedures that carry post-operative urinary retention risk after catheter removal, including TURP, holmium laser enucleation of the prostate (HoLEP), urethral stricture repair, and photoselective vaporization of the prostate (PVP). Discharge instructions after catheter removal must specify the voiding trial expectations: the expected time to first void after catheter removal (typically within 4 to 6 hours), the symptoms indicating successful voiding (stream caliber, absence of straining, absence of suprapubic pressure), and the criteria requiring return to the office or emergency department for catheter replacement (inability to void after 6 hours, suprapubic pain or distension, or post-void residual greater than 300 mL if portable bladder scan is available). Patients should receive instructions on the symptoms of early urinary tract infection after catheter removal: dysuria, urinary frequency, suprapubic discomfort, and fever.
- Gross hematuria management instructions are a specific documentation requirement for procedures that routinely produce post-operative hematuria, including TURP, HoLEP, transurethral resection of bladder tumor (TURBT), and ureteroscopy with laser lithotripsy. Discharge instructions must specify the expected hematuria duration and trajectory (for example, urine that appears pink to light rosé is expected after ureteroscopy and typically clears within 24 to 48 hours with oral hydration), the urine appearance that requires provider contact (dark red urine, passage of blood clots, or hematuria that worsens rather than improves after 48 hours), and the hydration instructions required to maintain adequate urinary flow and reduce clot retention risk. For patients discharged after TURP, instructions must specifically address clot retention as a cause of acute urinary obstruction requiring emergency evaluation.
- Urinary tract infection risk reduction documentation should specify the post-procedural antibiotic regimen where prescribed, the duration of the antibiotic course, and the criteria for completing versus discontinuing the antibiotic course. For patients not prescribed post-procedural antibiotics, discharge instructions should specify the signs of urinary tract infection requiring provider contact and the timeline for the initial post-operative urine culture or urinalysis where ordered. Patients with indwelling catheters are at highest risk of catheter-associated urinary tract infection (CAUTI), and discharge instructions should address catheter hygiene measures, fluid intake goals to maintain dilute urine and reduce infection risk, and the specific symptoms that warrant calling the provider rather than waiting for the scheduled follow-up appointment.
Procedure-Specific Discharge Documentation Requirements
- Radical prostatectomy discharge documentation must address catheter management instructions plus the specific post-prostatectomy recovery milestones and functional recovery expectations patients require to manage recovery outside the hospital setting. Activity restrictions after robotic-assisted laparoscopic radical prostatectomy (RALRP) include no lifting greater than 10 to 15 pounds for the first 4 weeks, no driving while the urethral catheter is in place, and no strenuous aerobic exercise for 4 to 6 weeks. Discharge instructions must also address port site wound care and the signs of port site infection or hernia development at the trocar sites. Expectations for urinary continence recovery after catheter removal should be documented: most RALRP patients experience some degree of stress urinary incontinence after catheter removal that typically improves over 3 to 12 months, and patients should receive specific instructions on pelvic floor exercises to begin after catheter removal to support continence recovery.
- Nephrectomy discharge documentation requirements vary by operative approach (open, laparoscopic, or robotic-assisted) and by the extent of resection (partial versus radical nephrectomy). After laparoscopic or robotic partial nephrectomy, discharge instructions must address port site wound care, drain management for patients discharged with a surgical drain, activity restrictions (typically no lifting greater than 10 to 15 pounds for 4 to 6 weeks), and the symptoms requiring prompt provider evaluation: fever above 101 degrees Fahrenheit, port site drainage, gross hematuria, and flank pain worsening rather than improving. Post-operative renal function monitoring is a specific concern after partial nephrectomy, and discharge instructions should specify whether a post-operative serum creatinine or metabolic panel was ordered, the timing of the laboratory test, and the process for reviewing results with the surgical team.
- Ureteroscopy and stone procedure discharge documentation must address the specific complications of ureteroscopy with laser lithotripsy: hematuria, renal colic from stone fragment passage, and ureteral stent symptoms where a stent was placed. For patients discharged with a ureteral stent, discharge instructions must specify the stent removal date and location, the expected stent-related symptoms (urinary frequency, urgency, dysuria, flank discomfort with voiding, and mild hematuria), the medications prescribed for stent symptom management, and the symptoms requiring emergency evaluation: fever with chills suggesting pyelonephritis, severe unilateral flank pain unresponsive to prescribed analgesia, or complete absence of urine output suggesting stent or ureteral obstruction. Patients who are unaware that a ureteral stent is a temporary device requiring scheduled removal are at risk for stent encrustation if the removal appointment is missed.
- Cystoscopy discharge documentation requirements apply to both diagnostic flexible cystoscopy and operative rigid cystoscopy. After diagnostic flexible cystoscopy, most patients are discharged without a catheter and require instructions on urinary burning or dysuria expected for 24 to 48 hours, the recommendation for increased fluid intake to reduce dysuria and flush the bladder, and the signs of urinary tract infection requiring provider contact. After TURBT, discharge instructions must address the extent of resection, expected hematuria duration, catheter management if a catheter was left in place, and the scheduled follow-up appointment for histopathology review. Patients who have undergone TURBT must also be informed of the post-procedure bladder instillation schedule if an intravesical agent was administered or is planned, as missed instillation appointments affect the oncologic management plan.
Structured Follow-Up Protocols to Reduce Preventable Readmissions
- A structured telephone or digital follow-up contact within 24 to 48 hours of discharge for high-risk urological procedures (radical prostatectomy, partial or radical nephrectomy, TURP, and HoLEP) reduces the rate of preventable readmission by enabling early identification of catheter dysfunction, post-operative bleeding, inadequate pain control, and other complications that can be managed in the ambulatory setting if identified before clinical deterioration requires emergency admission. Published evidence in the Journal of Urology and Urologic Oncology supports structured post-discharge telephone follow-up for radical prostatectomy patients as associated with reduced 30-day readmission and emergency department utilization. Practices should define a structured telephone follow-up protocol specifying the clinical criteria to be assessed, the clinical staff responsible for conducting the contact, and the escalation pathway for patients reporting concerning symptoms.
- Early catheter management follow-up scheduling reduces the risk of urinary retention and catheter-related readmission after prostatic procedures. After TURP, HoLEP, or photoselective vaporization of the prostate, a scheduled catheter removal appointment in the urology office within 24 to 72 hours of the procedure allows for voiding trial performance in a setting where prompt catheter reinsertion is available if the voiding trial fails. Practices that discharge patients with catheters without a scheduled in-office catheter removal appointment expose patients to the risk of self-removal or emergency department visits for catheter removal after failed home voiding. The scheduled catheter removal appointment should be documented in the discharge record including the date, time, and location of the appointment.
- Hydration and activity guidance documentation is a specific readmission risk reduction element for urological procedures because dehydration reduces urinary flow, increases infection risk, promotes stone fragment aggregation after lithotripsy, and increases the risk of clot retention after TURP or bladder procedures. Discharge instructions should specify a target daily fluid intake in measurable terms (for example, 2 to 3 liters of water or non-caffeinated fluid per day for the first 2 weeks after ureteroscopy) rather than general guidance to increase fluids. Activity restrictions should be procedure-specific and should include guidance on resuming driving (no driving while using scheduled opioid analgesics, no driving while an indwelling catheter is in place), sexual activity restrictions (typically 4 to 6 weeks after prostatectomy and 2 to 4 weeks after other open or laparoscopic procedures), and return to exercise (typically light walking from day 1 with progressive increase in activity over 4 to 6 weeks for minimally invasive procedures).
- Post-operative pain management documentation should specify the analgesic regimen prescribed, the expected duration of analgesic use, and the criteria for contacting the provider if pain is not controlled with the prescribed regimen. For minimally invasive urological procedures including laparoscopic nephrectomy and robotic prostatectomy, multimodal analgesia with scheduled acetaminophen, scheduled NSAIDs where not contraindicated by renal function or bleeding risk, and opioids reserved for breakthrough pain is associated with lower opioid consumption and reduced constipation-related complications compared to opioid-only regimens. Constipation prevention instructions are a specific readmission risk reduction measure after urological surgery because post-operative constipation increases straining, raises intraabdominal pressure, and exacerbates post-prostatectomy urinary incontinence. Discharge instructions should specify the bowel regimen prescribed and the escalation steps if the patient has not had a bowel movement within 48 hours of surgery.